Table 2.

Performance evaluation of the diabetic retinopathy (DR) and age-related macular degeneration (AMD) screening systems on the prospective dataset with accuracy, sensitivity, specificity, and kappa scores measured against adjudicated human grading

Metric	AMD screening	DR screening
Sensitivity	86.6% (80.6% to 91.3%)	97.0% (84.2% to 99.9%)
Specificity	92.1% (89.4% to 94.3%)	96.3% (94.5% to 97.6%)
Accuracy	90.7% (88.2% to 92.8%)	96.3% (94.6% to 97.6%)
Kappa score	0.76 (0.71 to 0.82)	0.70 (0.59 to 0.81)